Publications (48) View all
-
Article: Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes.
Neekesh V Dharia, A Taylor Bright, Scott J Westenberger, S Whitney Barnes, Serge Batalov, Kelli Kuhen, Rachel Borboa, Glenn C Federe, Colleen M McClean, Joseph M Vinetz, Victor Neyra, Alejandro Llanos-Cuentas, John W Barnwell, John R Walker, Elizabeth A Winzeler[show abstract] [hide abstract]
ABSTRACT: Plasmodium vivax causes 25-40% of malaria cases worldwide, yet research on this human malaria parasite has been neglected. Nevertheless, the recent publication of the P. vivax reference genome now allows genomics and systems biology approaches to be applied to this pathogen. We show here that whole-genome analysis of the parasite can be achieved directly from ex vivo-isolated parasites, without the need for in vitro propagation. A single isolate of P. vivax obtained from a febrile patient with clinical malaria from Peru was subjected to whole-genome sequencing (30× coverage). This analysis revealed over 18,261 single-nucleotide polymorphisms (SNPs), 6,257 of which were further validated using a tiling microarray. Within core chromosomal genes we find that one SNP per every 985 bases of coding sequence distinguishes this recent Peruvian isolate, designated IQ07, from the reference Salvador I strain obtained in 1972. This full-genome sequence of an uncultured P. vivax isolate shows that the same regions with low numbers of aligned sequencing reads are also highly variable by genomic microarray analysis. Finally, we show that the genes containing the largest ratio of nonsynonymous-to-synonymous SNPs include two AP2 transcription factors and the P. vivax multidrug resistance-associated protein (PvMRP1), an ABC transporter shown to be associated with quinoline and antifolate tolerance in Plasmodium falciparum. This analysis provides a data set for comparative analysis with important potential for identifying markers for global parasite diversity and drug resistance mapping studies.Proceedings of the National Academy of Sciences 10/2010; 107(46):20045-50. · 9.68 Impact Factor -
Article: Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency.
Rodolfo Gonzalez, Lori L Jennings, Mark Knuth, Anthony P Orth, Heath E Klock, Weija Ou, Julie Feuerhelm, Mitchell V Hull, Eric Koesema, Yuping Wang, [......], Andrew I Su, Serge Batalov, Hong Chen, Kristen Johnson, Bryan Laffitte, Deborah G Nguyen, Evan Y Snyder, Peter G Schultz, Jennifer L Harris, Scott A Lesley[show abstract] [hide abstract]
ABSTRACT: Approximately 3,500 mammalian genes are predicted to be secreted or single-pass transmembrane proteins. The function of the majority of these genes is still unknown, and a number of the encoded proteins might find use as new therapeutic agents themselves or as targets for small molecule or antibody drug development. To analyze the physiological activities of the extracellular proteome, we developed a large-scale, high-throughput protein expression, purification, and screening platform. For this study, the complete human extracellular proteome was analyzed and prioritized based on genome-wide disease association studies to select 529 initial target genes. These genes were cloned into three expression vectors as native sequences and as N-terminal and C-terminal Fc fusions to create an initial collection of 806 purified secreted proteins. To determine its utility, this library was screened in an OCT4-based cellular assay to identify regulators of human embryonic stem-cell self-renewal. We found that the pigment epithelium-derived factor can promote long-term pluripotent growth of human embryonic stem cells without bFGF or TGFbeta/Activin/Nodal ligand supplementation. Our results further indicate that activation of the pigment epithelium-derived factor receptor-Erk1/2 signaling pathway by the pigment epithelium-derived factor is sufficient to maintain the self-renewal of pluripotent human embryonic stem cells. These experiments illustrate the potential for discovering novel biological functions by directly screening protein diversity in cell-based phenotypic or reporter assays.Proceedings of the National Academy of Sciences 02/2010; 107(8):3552-7. · 9.68 Impact Factor -
Conference Proceeding: Automated Microscopy Screen to Identify Components Required for Mitotic Cell Cycle Progression in Human Cells.
Daniel R. Rines, Mariana Gomez, Yingyao Zhou, Paul DeJesus, Seanna Grob, Serge Batalov, Marc Labow, Dieter Huesken, Craig Mickanin, Jonathan Hall, Mischa Reinhardt, Francois Natt, Joerg Lange, David J. Sharp, Sumit K. Chanda, Jeremy S. CaldwellProceedings of the 2007 IEEE International Symposium on Biomedical Imaging: From Nano to Macro, Washington, DC, USA, April 12-16, 2007; 01/2007 -
SourceAvailable from: Kazunori Waki
Article: Antisense transcription in the mammalian transcriptome.
S Katayama, Y Tomaru, T Kasukawa, K Waki, M Nakanishi, M Nakamura, H Nishida, C C Yap, M Suzuki, J Kawai, [......], S Batalov, P G Engström, Y Mizuno, M A Faghihi, A Sandelin, A M Chalk, S Mottagui-Tabar, Z Liang, B Lenhard, C Wahlestedt[show abstract] [hide abstract]
ABSTRACT: Antisense transcription (transcription from the opposite strand to a protein-coding or sense strand) has been ascribed roles in gene regulation involving degradation of the corresponding sense transcripts (RNA interference), as well as gene silencing at the chromatin level. Global transcriptome analysis provides evidence that a large proportion of the genome can produce transcripts from both strands, and that antisense transcripts commonly link neighboring "genes" in complex loci into chains of linked transcriptional units. Expression profiling reveals frequent concordant regulation of sense/antisense pairs. We present experimental evidence that perturbation of an antisense RNA can alter the expression of sense messenger RNAs, suggesting that antisense transcription contributes to control of transcriptional outputs in mammals.Science 10/2005; 309(5740):1564-6. · 31.20 Impact Factor -
SourceAvailable from: Winston Hide
Article: The transcriptional landscape of the mammalian genome.
P Carninci, T Kasukawa, S Katayama, J Gough, M C Frith, N Maeda, R Oyama, T Ravasi, B Lenhard, C Wells, [......], K Shibata, T Shiraki, S Suzuki, M Tagami, K Waki, A Watahiki, Y Okamura-Oho, H Suzuki, J Kawai, Y Hayashizaki[show abstract] [hide abstract]
ABSTRACT: This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5' and 3' boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.Science 10/2005; 309(5740):1559-63. · 31.20 Impact Factor